The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery

Anesthesia and Analgesia

Volumn 85, Issue 6, 1997, Pages 1394-1398

  Gilliland, Helen E ^a,b   Armstrong, Marilyn A ^a   Carabine, Una ^a   McMurray, Terence J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ULSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; ISOFLURANE; PROPOFOL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION RISK; INTRAVENOUS ANESTHESIA; PRIORITY JOURNAL; SURGICAL RISK;

ADULT; ANESTHESIA; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CYTOKINES; FEMALE; HUMANS; HYSTERECTOMY; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; ISOFLURANE; MIDDLE AGED; PROPOFOL; RECEPTORS, INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031407486     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199712000-00039     Document Type: Article

References (25)

1. Miller LC, Lynch EA, Isa S, et al. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993;341:146-8.
2. McBride WT, Armstrong MA, Crockard AD, et al. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995;75:724-33.
3. Crozier TA, Muller JE, Quittkat D, et al. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994;72:280-5.
4. Pirttikangas CO, Salo M, Mansikka M, et al. The influence of anaesthetic technique upon the immune response to hysterectomy: a comparison of propofol infusion and isoflurane. Anaesthesia 1995;50:1056-61.
5. Rossano F, Tufano R, Cipolaro-de-L'Ergo G, et al. Anesthetic agents induce human mononuclear leukocytes to release cytokines. Immunopharmacol Immunotoxicol 1992;14:439-50.
6. Salo M, Pirttikangas CO, Pulkki K. Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia 1997;52:341-4.
7. Roberts FL, Dixon J, Lewis GT, et al. Induction and maintenance of propofol anaesthesia. Anaesthesia 1988;43(Suppl):14-7.
8. Dehoux M, Philip I, Chollet-Martin S, et al. Early production of interleukin-10 during normothermic cardiopulmonary bypass [letter]. J Thorac Cardiovasc Surg 1995;110:286-7.
9. Tracey KJ, Lowry SF, Cerami A. Cachectin/TNF-α in septic shock and septic adult repiratory distress syndrome. Am Rev Respir Dis 1988;138:1377-9.
10. Calandra T, Baumgartner J-D, Grau GE, et al. Prognostic values of tumor necrosis factor/cachectin, interluekin-1, interferon alpha and interferon gamma in the serum of patients with septic shock. J Infect Dis 1990;161:982-7.
11. Nawroth PP, Bank I, Handley D, et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1. J Exp Med 1986;163:1363-75.
12. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
13. Cruickshank AM, Fraser WD, Burns HJ, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Science 1990;79:161-5.
14. Peterson PK, Sharp B, Gekker G, et al. Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest 1987;80:824-31.
15. Ertel W, Faist E, Nestle C, et al. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res 1990;48:622-8.
16. Ashcroft GS, Masterson GR. Interleukin-6 and wound healing [letter]. Br J Anaesth 1994;73:426.
17. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
18. deWaal-Malefyt R, Haanen J, Spits H, et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.
19. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177: 1205-8.
20. Chernoff AE, Granowitz EV, Shapiro L, et al. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154:5492-9.
21. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet Al radiation. J Invest Dermatol 1995;104:3-6.
22. Mantz J, Delumeau JC, Cordier J, Petitet F. Differential effects of propofol and ketamine on cytosolic calcium concentrations of astrocytes in primary culture. Br J Anaesth 1994;72:351-3.
23. 2+] in cultured rat hippocampal neurons. Neuropharmacology 1995;34:541-51.
24. Fisher CJ Jr, Dhainaut JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial - phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994; 271:1836-43.
25. Cassatella MA, Meda L, Gasperini S, et al. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994;179: 1695-9.